1 |
Parik Kakani,Shrutu G Dhamdhere,Deepak Pant,Rushikesh Joshi,Jharna Mishra,Atul Samaiya,Sanjeev Shukla |
1 Kakani P, Dhamdhere S, Pant D, Joshi R, Mishra J, Samaiya A, Shukla S*. “Hypoxia-induced CTCF promotes EMT in breast cancer |
6421 |
Cell Reports |
2024 |
2 |
Anchala Pandey,Parik Kakani,Sanjeev Shukla |
CTCF and BORIS-mediated autophagy regulation via alternative splicing of BNIP3L in breast cancer |
6423 |
Journal of Biological Chemistry |
2024 |
3 |
Palma FR,Gantner BN,Sakiyama MJ,Kayzuka C,Shukla S,Lacchini R,Cunniff B,Bonini MG |
ROS production by mitochondria: function or dysfunction? |
5451 |
Oncogene |
2024 |
4 |
Yadav P,Pandey A,Kakani P,Mutnuru A S,Samaiya A,Mishra J,Shukla S |
Hypoxia-induced loss of SRSF2-dependent DNA methylation promotes CTCF-mediated alternative splicing of VEGFA in breast cancer |
4911 |
iScience |
2023 |
5 |
Madhura R Pandkar,Adarsh Raveendran,Kajal Biswas,Srinivas Abhishek Mutnuru,Jharna Mishra,Atul Samaiya,Tyler Malys,Alexander Y Mitrophanov,Shyam K Sharan,Sanjeev Shukla |
PKM2 dictates the poised chromatin state of PFKFB3 promoter to enhance breast cancer progression |
4913 |
NAR Cancer |
2023 |
6 |
Madhura R Pandkar,Sommya Sinha,Atul Samaiya,Sanjeev Shukla |
Oncometabolite lactate enhances breast cancer progression by orchestrating histone lactylation-dependent c-Myc expression |
4915 |
Translational Oncology |
2023 |
7 |
Mishra T,Bhardwaj V,Ahuja N,Gadgil P,Ramdas P,Shukla S,Chande A |
Improved loss-of-function CRISPR/Cas9 genome editing in human cells concomitant with inhibition of TGF? signaling. |
4903 |
Molecular Therapy - Nucleic Acids |
2022 |
8 |
Mishra T,Dalavi R,Joshi G,Kumar A,Pandey P,Shukla S,Mishra K R,Chande A |
The role of SARS CoV-2 spike NTD mutations in determining neutralization susceptibility and virion infectivity |
4905 |
Life Science Alliance |
2022 |
9 |
Reddy C N,Molla R,Joshi N P,Sajeev K T,Basu I,Kawadkar J,Kalra N,Mishra K R,Chakrabarty S,Shukla S,Rai V |
Traceless cysteine-linchpin enables precision engineering of lysine in native proteins |
4907 |
Nature Communications ( Open Access from 2016) |
2022 |
10 |
Thakur K,Sajeev K T,Singh K S,Ragendu V,Rawale G D,Adusumalli R S,Kalra N,Shukla S,Mishra K R,Rai V |
Human Behavior-Inspired Linchpin-Directed Catalysis for Traceless Precision Labeling of Lysine in Native Proteins |
4909 |
Bioconjugate Chemistry |
2022 |
11 |
Subhashis Natua,Shruti Ganesh Dhamdhere,Srinivas Abhishek Mutnuru,Sanjeev Shukla |
Interplay within tumor microenvironment orchestrates neoplastic RNA metabolism and transcriptome diversity |
3091 |
WIREs RNA |
2021 |
12 |
Atul Samaiya,Jharna Mishra,Subhashis Natua,Neha Ahuja,Cheemala Ashok,Sanjeev Shukla |
E2F1 and epigenetic modifiers orchestrate breast cancer progression by regulating oxygen-dependent ESRP1 expression |
3131 |
Oncogenesis |
2021 |
13 |
Anchala Pandey,Pooja Yadav,Sanjeev Shukla |
Unfolding the role of autophagy in the cancer metabolism |
3439 |
Biochem. & Biophy. Reports |
2021 |
14 |
Sandhya Yadav,Deepak Pant,Atul Samaiya,Neetu Kalra,Sanjay Gupta,Sanjeev Shukla |
ERK1/2-EGR1-SRSF10 Axis Mediated Alternative Splicing Plays a Critical Role in Head and Neck Cancer |
3197 |
Frontiers in Cell and Developmental Biology |
2021 |
15 |
Shubhashis Natua,Ashok Cheemala,Sanjeev Shukla |
Hypoxia-induced alternative splicing in human diseases: the pledge, the turn, and the prestige |
2447 |
Cell and Molecular Life Sciences |
2021 |
16 |
Arpankumar Choksi,Apoorva Parulekar,Richa Pant,Vibhuti Kumar Shah,Ramakrishna Nimma,Priyanka Firmal,Smriti Singh,Gopal C. Kundu,Sanjeev Shukla, Samit Chattopadhyay |
Tumor suppressor SMAR1 regulates PKM alternative splicing by HDAC6-mediated deacetylation of PTBP1 |
3021 |
BMC Cancer & Metabolism |
2021 |
17 |
Madhura R Pandkar,Shruti G Dhamdhere,Sanjeev Shukla |
Oxygen gradient and tumor heterogeneity: The chronicle of a toxic relationship |
3025 |
BBA Reviews on Cancer |
2021 |
18 |
Atul Samaiya,Sanjeev Shukla,Jharna Mishra,Vishnu Narayanan SS,Pooja Yadav,Madhura R Pandkar,Anna Cherian,Deepak Pant,Subhashis Natua,Cheemala Ashok,Neha Ahuja |
Hypoxia-induced TGFb-RBFOX2-ESRP1 axis regulates human MENA alternative splicing and promotes EMT in breast cancer |
2337 |
NAR Cancer |
2020 |
19 |
Deepak Pant,Sathiya P Narayanan ,Nagarjun Vijay,Sanjeev Shukla |
Hypoxia-induced changes in intragenic DNA methylation correlate with alternative splicing in breast cancer |
2095 |
Journal of Biosciences |
2020 |
20 |
S R Adusumalli,D G Rawale,K Thakur,L Purushottam,N C Reddy,N Kalra,S Shukla,V Rai |
Chemoselective and Siteâ€Selective Lysineâ€Directed Lysine Modification Enables Singleâ€Site Labeling of Native Proteins |
2097 |
Angewandte Chemie International Edition |
2020 |
21 |
Atul Samaiya,Jharna Mishra,Archana P T,Sandhya Yadav,Amit Gupta,Sanjeev Shukla |
HNRNP2B1-MST1R-AKT axis contributes to the EMT in head and neck cancer |
2225 |
Nature Laboratory Investigation |
2020 |
22 |
M Chilamari,N Kalra,S Shukla,Rai Vishal |
Single-site labeling of lysine in proteins through a metal-free multicomponent approach |
1335 |
Chemical Communications |
2018 |
23 |
S R Adusumalli ,D G Rawale ,U Singh,P Tripathi,R Paul,N Kalra,R K Mishra,S Shukla,V Rai |
Single-Site Labeling of Native Proteins Enabled by a Chemoselective and Site-Selective Chemical Technology |
1336 |
J.Am.Chem.Soc |
2018 |
24 |
Sanjeev Shukla,Atul Samaiya,Rajendra Kumar Panday,Smriti Singh,Athira Ajith,Amit Gupta |
PAK2–c-Myc–PKM2 axis plays an essential role in head and neck oncogenesis via regulating Warburg effect |
1202 |
Cell Death and Disease |
2018 |
25 |
Sathiya Pandi Narayanan,Smriti Singh,Sanjeev Shukla |
A saga of cancer epigenetics: linking epigenetics to alternative splicing |
674 |
Biochemical J |
2017 |
26 |
Atul Samaiya,Rajendra Kumar Panday,Sandhya Yadav,Neha Ahuja,Amit Gupta,Kajal Biswas,Sathiya Pandi Narayanan,Smriti Singh,Shyam K Sharan,Sanjeev Shukla |
Intragenic DNA methylation and BORIS-mediated cancer-specific splicing contribute to the Warburg effect |
965 |
Proceedings of the National Academy of Sciences |
2017 |
27 |
Nazmul Haque,Sanjeev Shukla,Kyster K Nanan,Maria F Prigge,Garima Verma,Morgan Thenoz,Marc A Bailly,David Sturgill,Ryan J Marina,Shalini Oberdoerffer |
TET-catalyzed oxidation of intragenic 5-methylcytosine regulates CTCF-dependent alternative splicing |
134 |
EMBO J |
2016 |
28 |
Sathiya Pandi Narayanan,Smriti Singh,Amit Gupta,Sandhya Yadav,Shree Ram Singh,Sanjeev Shukla |
Integrated genomic analyses identify KDM1A’s role in cell proliferation via modulating E2F signaling activity and associate with poor clinical outcome in oral cancer |
133 |
Cancer Letters |
2015 |
29 |
Sanjeev Shukla,E Kavak ,M Gregory ,M Imashimizu , B Shutinoski,M Kashlev ,P Oberdoerffer ,R Sandberg,S Oberdoerffer |
CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing |
4917 |
Nature ( Through e-Shodh Sindhu) |
2011 |